GeoVax Labs provides updates on HIV-1 vaccine trials (News-Medical-Net)

February 9th, 2010 by admin

GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today provided an update on its vaccine trials progress.